TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T28330	Cholecystokinin receptor type A	B0OJM5	(3S)-3-{[(2S)-1-[(2S)-2-{2-[(2R)-2-[(2S)-2-Amino-3-(4-hydroxyphenyl)propanamido]propanamido]acetamido}-3-phenylpropanehydrazido]-1-oxo-3-phenylpropan-2-yl]carbamoyl}-3-[(2S)-2-[(2R)-2-{[(tert-butoxy)carbonyl]amino}-3-(1H-indol-2-yl)propanamido]hexanamido]propanoic acid	Investigative	44418923	C58H73N11O13	1132.3	CCCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)NC(=O)[C@@H](CC4=CC5=CC=CC=C5N4)NC(=O)OC(C)(C)C	IC50 = 28200000000000 nM	Non binder
T28330	Cholecystokinin receptor type A	B1DPR5	(3S)-3-[(2S)-2-[(2R)-2-Amino-3-(1H-indol-2-yl)propanamido]hexanamido]-3-{[(2S)-1-[(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]acetamido}-3-phenylpropanehydrazido]-1-oxo-3-phenylpropan-2-yl]carbamoyl}propanoic acid	Investigative	44418924	C53H65N11O11	1032.099	CCCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)NC(=O)[C@@H](CC4=CC5=CC=CC=C5N4)N	IC50 = 97700000000000 nM	Non binder
T28330	Cholecystokinin receptor type A	B6HK2G	(3S)-3-Amino-4-[[(2S)-1-[[(2S)-1-[[(3S,6S,9S,12S,15S,18S)-6-benzyl-9-(carboxymethyl)-15-(1H-indol-3-ylmethyl)-3-methyl-12-(2-methylsulfanylethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,16-hexazacyclononadec-18-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1-oxo-3-(4-sulfooxyphenyl)propan-2-yl]amino]-4-oxobutanoic acid	Investigative	23652473	C53H67N11O17S3	1226.4	C[C@H]1C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC2=CC=CC=C2)CC(=O)O)CCSC)CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC5=CC=C(C=C5)OS(=O)(=O)O)NC(=O)[C@H](CC(=O)O)N	IC50 > 1000000 nM	Non binder
T28330	Cholecystokinin receptor type A	BC0PG5	H-Tyr-D-Ala-Gly-Phe-NH-NH-D-Phe-D-Asp-D-Nle-Trp-Boc	Investigative	16100408	C58H73N11O13	1132.3	CCCC[C@H](C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)NNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)NC(=O)[C@H](CC4=CC5=CC=CC=C5N4)NC(=O)OC(C)(C)C	IC50 = 112000000000000 nM	Non binder
T28330	Cholecystokinin receptor type A	BCK3U8	H-Tyr-D-Ala-Gly-Phe-NH-NH-Trp-D-Nle-D-Asp-D-Phe-Boc	Investigative	16100406	C58H73N11O13	1132.3	CCCC[C@H](C(=O)N[C@@H](CC1=CC2=CC=CC=C2N1)C(=O)NNC(=O)[C@H](CC3=CC=CC=C3)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](CC4=CC=C(C=C4)O)N)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC5=CC=CC=C5)NC(=O)OC(C)(C)C	IC50 = 7590000000000000 nM	Non binder
T28330	Cholecystokinin receptor type A	D0S7SO	H-Tyr-D-Ala-Gly-Phe-NH-NH-D-Trp-Nle-Asp-Phe-Bo	Investigative	16100407	C58H73N11O13	1132.3	CCCC[C@@H](C(=O)N[C@H](CC1=CC2=CC=CC=C2N1)C(=O)NNC(=O)[C@H](CC3=CC=CC=C3)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](CC4=CC=C(C=C4)O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)OC(C)(C)C	IC50 = 851000000000 nM	Non binder